• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver biopsies and methotrexate: a time for reconsideration?

作者信息

Zachariae H

机构信息

Department of Dermatology, Marselisborg Hospital, University of Aarhus, Denmark.

出版信息

J Am Acad Dermatol. 2000 Mar;42(3):531-4. doi: 10.1016/s0190-9622(00)90237-8.

DOI:10.1016/s0190-9622(00)90237-8
PMID:10688735
Abstract
摘要

相似文献

1
Liver biopsies and methotrexate: a time for reconsideration?肝活检与甲氨蝶呤：是时候重新考虑了吗？
J Am Acad Dermatol. 2000 Mar;42(3):531-4. doi: 10.1016/s0190-9622(00)90237-8.
2
Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.对使用甲氨蝶呤的患者进行监测：血清III型前胶原氨基端肽检测正常的患者未出现肝纤维化。
Br J Dermatol. 2005 Mar;152(3):451-8. doi: 10.1111/j.1365-2133.2005.06459.x.
3
The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.III型前胶原氨基端前肽在甲氨蝶呤诱导的肝纤维化常规筛查中的价值：一项10年随访研究
Br J Dermatol. 2001 Jan;144(1):100-3. doi: 10.1046/j.1365-2133.2001.03959.x.
4
Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.用于检测甲氨蝶呤治疗的银屑病患者肝纤维化的前胶原-3 N端肽测量：日常实践应用及临床意义
Br J Dermatol. 2017 Nov;177(5):1454-1457. doi: 10.1111/bjd.15313. Epub 2017 Sep 10.
5
Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.甲氨蝶呤所致肝纤维化和肝硬化是否已变得罕见？这是一个需要重新评估常规肝活检的问题。
Dermatology. 2005;211(4):307-8. doi: 10.1159/000088497.
6
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.用Ⅲ型前胶原氨基端肽替代常规肝活检来监测接受长期甲氨蝶呤治疗的银屑病患者：一项多中心审计与卫生经济学分析
Br J Dermatol. 2005 Mar;152(3):444-50. doi: 10.1111/j.1365-2133.2005.06422.x.
7
Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.甲氨蝶呤治疗的肝组织学正常的银屑病患者血清III型前胶原氨基端肽异常与肝脏超微结构改变无关。
Br J Dermatol. 1995 Oct;133(4):512-8. doi: 10.1111/j.1365-2133.1995.tb02697.x.
8
Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?甲氨蝶呤治疗银屑病期间的肝功能监测：常规活检真的有必要吗？
Am J Clin Dermatol. 2005;6(6):357-63. doi: 10.2165/00128071-200506060-00003.
9
Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.甲氨蝶呤所致肝硬化。临床、组织学及血清学研究——又一个10年随访
Dermatology. 1996;192(4):343-6. doi: 10.1159/000246408.
10
Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.银屑病及银屑病关节炎患者血清III型前胶原氨基端前肽水平与肝纤维化的关系
J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):509. doi: 10.1016/s0190-9622(08)80593-2.

引用本文的文献

1
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?银屑病、代谢综合征与甲氨蝶呤：这种关联是否适用于脂肪性肝病中的一个新亚类？
World J Hepatol. 2025 Apr 27;17(4):102978. doi: 10.4254/wjh.v17.i4.102978.
2
Total Cumulative Dose of Methotrexate is Not the Same as Continuous Cumulative Dose: A Clinician's Perspective.甲氨蝶呤的总累积剂量与持续累积剂量不同：临床医生视角
Indian Dermatol Online J. 2020 May 10;11(3):425-427. doi: 10.4103/idoj.IDOJ_361_19. eCollection 2020 May-Jun.
3
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C.
甲氨蝶呤与慢性丙型肝炎的类风湿关节炎患者人群中肝硬化的增加无关。
Sci Rep. 2016 Sep 9;6:33104. doi: 10.1038/srep33104.
4
Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?银屑病中肝脏硬度测量：代谢因素还是疾病因素起重要作用？
Biomed Res Int. 2016;2016:7963972. doi: 10.1155/2016/7963972. Epub 2016 Feb 23.
5
Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.在一个基于人群的慢性乙型肝炎类风湿关节炎患者队列中，甲氨蝶呤与肝硬化增加无关。
Sci Rep. 2016 Mar 1;6:22387. doi: 10.1038/srep22387.
6
Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis.亚洲银屑病患者甲氨蝶呤肝毒性的患病率及危险因素
World J Hepatol. 2013 May 27;5(5):275-80. doi: 10.4254/wjh.v5.i5.275.
7
Comparative tolerability of systemic treatments for plaque-type psoriasis.斑块型银屑病全身治疗的耐受性比较
Drug Saf. 2002;25(13):913-27. doi: 10.2165/00002018-200225130-00003.
8
Psoriasis in children: a guide to its diagnosis and management.儿童银屑病：诊断与管理指南
Paediatr Drugs. 2001;3(9):673-80. doi: 10.2165/00128072-200103090-00005.
9
Management of drug-induced liver disease.药物性肝病的管理
Curr Gastroenterol Rep. 2001 Feb;3(1):38-48. doi: 10.1007/s11894-001-0039-y.